User: I want to create a SMILES.
Assistant: This sounds very interesting. Should I consider any constraints for the generation?
User: Yes, please. The molecule should have a drug half life time in humans after IV administration value of approximately 24.000 hours.
Assistant: Got it, this SMILES has a drug half life time in humans after IV administration value of approximately 24.000 hours: CN[C@@H]1[C@@H](O)[C@@H](O[C@@H]2[C@@H](O)[C@H](O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3O)[C@@H](N)C[C@H]2NC(=O)[C@@H](O)CN)OC[C@]1(C)O
User: I want to {#come up with|create|generate!} a {#molecule |!}{SMILES__description}.
Assistant: {#This sounds very exciting. |This sounds very interesting. !}Should I consider any {#constraints|specific points!} for the {#generation|creation!}?
User: Yes, please. The molecule should have a {half_life_duration__names__noun} value of approximately {half_life_duration#} {half_life_duration__units}.
Assistant: {#Ok|Got it!},{# here you go,|!} this {SMILES__description} has a {half_life_duration__names__noun} value of approximately {half_life_duration#} {half_life_duration__units}: {SMILES#}
(2S)-3-amino-N-[(1R,2S,3S,4R,5S)-5-amino-4-[(2R,3R,4S,5S,6R)-6-(aminomethyl)-3,4,5-trihydroxyoxan-2-yl]oxy-2-[(2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methylamino)oxan-2-yl]oxy-3-hydroxycyclohexyl]-2-hydroxypropanamide